LBA30 ATHENA-COMBO, a phase III, randomized trial comparing rucaparib (RUCA) + nivolumab (NIVO) combination therapy vs RUCA monotherapy as maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC)
2024 · Annals of Oncology · 29 citations
https://doi.org/10.1016/j.annonc.2024.08.2269